Brainscope Ahead 200

BRAINSCOPE COMPANY, INC. · K143643 · 2015-05-15

Brainscope Ahead 200 is an AI-enabled medical device from BRAINSCOPE COMPANY, INC., listed by FDA (510(k), K143643) with a decision date of 2015-05-15. Review panel: Neurology.

FDA submission numberK143643
Pathway510(k)
CompanyBRAINSCOPE COMPANY, INC.
Review panel (specialty)Neurology
FDA decision date2015-05-15
DecisionSubstantially Equivalent
Product codePIW
ClassificationBrain Injury Adjunctive Interpretive Electroencephalograph Assessment Aid
Device class2
Regulation number882.1450
Review time (calendar days)144
Applicant countryUS

Official FDA database record · FDA AI-enabled device list

More devices from BRAINSCOPE COMPANY, INC. · All Neurology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.